Heart Test Laboratories (NASDAQ:HSCS – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Ascendiant Capital Markets in a research note issued on Monday, Benzinga reports. They presently have a $15.00 price objective on the stock. Ascendiant Capital Markets’ price target would suggest a potential upside of 252.94% from the stock’s previous close.
Heart Test Laboratories Stock Up 44.6 %
Shares of HSCS stock opened at $4.25 on Monday. The business has a 50-day moving average price of $3.39 and a two-hundred day moving average price of $6.44. Heart Test Laboratories has a 12-month low of $2.36 and a 12-month high of $52.00. The firm has a market cap of $2.79 million, a P/E ratio of -0.09 and a beta of 3.13.
Heart Test Laboratories Company Profile
Featured Articles
- Five stocks we like better than Heart Test Laboratories
- 3 Best Fintech Stocks for a Portfolio Boost
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is a SEC Filing?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.